Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C100496200 on October 18, 2001

J. Biol. Chem., Vol. 276, Issue 49, 46099-46103, December 7, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/49/46099    most recent
C100496200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gross, S. D.
Right arrow Articles by Maller, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gross, S. D.
Right arrow Articles by Maller, J. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Constitutively Active Form of the Protein Kinase p90Rsk1 Is Sufficient to Trigger the G2/M Transition in Xenopus Oocytes*

Stefan D. GrossDagger , Andrea L. Lewellyn, and James L. Maller§

From the Howard Hughes Medical Institute and Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado 80262

The protein kinase p90Rsk has previously been implicated as a key target of the MAPK pathway during M phase of meiosis II in Xenopus oocytes. To determine whether Rsk is a mediator of MAPK for stimulation of the G2/M transition early in meiosis I, we sought to generate a form of Rsk that would be constitutively active in resting, G2 phase oocytes. Initial studies revealed that an N-terminal truncation of 43 amino acids conferred enhanced specific activity on the enzyme in G2 phase, and stability was highest if the C terminus was not truncated. The full-length enzyme is known to be activated by phosphorylation at five sites. Two of these sites and flanking residues were replaced with either aspartic or glutamic acid, and Tyr699 was mutated to alanine. The resulting construct, termed fully activated (FA) Rsk, had constitutive activity in G2 phase, with a specific activity equivalent to that of wild type Rsk in M phase. In eight independent experiments ~45% of oocytes expressing FA-Rsk underwent germinal vesicle breakdown (GVBD, the G2/M transition) in the absence of progesterone, and this effect could be observed even in the presence of the MAPK kinase inhibitor U0126. Moreover, the specific activity of FA-Rsk in vivo was unaffected by U0126. In oocytes that did not undergo GVBD with FA-Rsk expression, subsequent treatment with progesterone resulted in a very rapid rate of GVBD even in the presence of U0126 to inhibit the endogenous MAPK/Rsk pathway. These results indicate that Rsk is the mediator of MAPK effects for the G2/M transition in meiosis I and in a subpopulation of oocytes Rsk is sufficient to trigger the G2/M transition.


* This work was supported by Grant DK28353-20 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger An Associate of the Howard Hughes Medical Institute. Present address: Agouron Pharmaceuticals, La Jolla, CA 92037.

§ An Investigator of the Howard Hughes Medical Institute. To whom correspondence should be addressed: HHMI/Dept. of Pharmacology, University of Colorado School of Medicine, 4200 E. 9th Ave., Denver, CO 80262. Tel.: 303-315-7075; Fax: 303-315-7160; E-mail: Jim.Maller@uchsc.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RNAHome page
A. Git, R. Allison, E. Perdiguero, A. R. Nebreda, E. Houliston, and N. Standart
Vg1RBP phosphorylation by Erk2 MAP kinase correlates with the cortical release of Vg1 mRNA during meiotic maturation of Xenopus oocytes
RNA, June 1, 2009; 15(6): 1121 - 1133.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-Q. Dai, X.-J. Zhu, F.-Q. Liu, J.-H. Xiang, H. Nagasawa, and W.-J. Yang
Involvement of p90 Ribosomal S6 Kinase in Termination of Cell Cycle Arrest during Development of Artemia-encysted Embryos
J. Biol. Chem., January 18, 2008; 283(3): 1705 - 1712.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Josefsberg Ben-Yehoshua, A. L. Lewellyn, P. Thomas, and J. L. Maller
The Role of Xenopus Membrane Progesterone Receptor {beta} in Mediating the Effect of Progesterone on Oocyte Maturation
Mol. Endocrinol., March 1, 2007; 21(3): 664 - 673.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. A. Dummler, C. Hauge, J. Silber, H. G. Yntema, L. S. Kruse, B. Kofoed, B. A. Hemmings, D. R. Alessi, and M. Frodin
Functional Characterization of Human RSK4, a New 90-kDa Ribosomal S6 Kinase, Reveals Constitutive Activation in Most Cell Types
J. Biol. Chem., April 8, 2005; 280(14): 13304 - 13314.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Silverman, M. Frodin, S. Gammeltoft, and J. L. Maller
Activation of p90Rsk1 Is Sufficient for Differentiation of PC12 Cells
Mol. Cell. Biol., December 15, 2004; 24(24): 10573 - 10583.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Erikson, T. A. J. Haystead, Y.-W. Qian, and J. L. Maller
A Feedback Loop in the Polo-like Kinase Activation Pathway
J. Biol. Chem., July 30, 2004; 279(31): 32219 - 32224.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
P. P. Roux and J. Blenis
ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions
Microbiol. Mol. Biol. Rev., June 1, 2004; 68(2): 320 - 344.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. P. Myers, L. B. Corson, J. Rossant, and J. C. Baker
Characterization of Mouse Rsk4 as an Inhibitor of Fibroblast Growth Factor-RAS-Extracellular Signal-Regulated Kinase Signaling
Mol. Cell. Biol., May 15, 2004; 24(10): 4255 - 4266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Baert, J.-F. Bodart, B. Bocquet-Muchembled, A. Lescuyer-Rousseau, and J.-P. Vilain
Xp42Mpk1 Activation Is Not Required for Germinal Vescicle Breakdown but for Raf Complete Phosphorylation in Insulin-stimulated Xenopus Oocytes
J. Biol. Chem., December 12, 2003; 278(50): 49714 - 49720.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. M. Eisenmann, M. W. VanBrocklin, N. A. Staffend, S. M. Kitchen, and H.-M. Koo
Mitogen-Activated Protein Kinase Pathway-Dependent Tumor-Specific Survival Signaling in Melanoma Cells through Inactivation of the Proapoptotic Protein Bad
Cancer Res., December 1, 2003; 63(23): 8330 - 8337.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
B. J. Tunquist and J. L. Maller
Under arrest: cytostatic factor (CSF)-mediated metaphase arrest in vertebrate eggs
Genes & Dev., March 15, 2003; 17(6): 683 - 710.
[Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. Walsh, S. S. Margolis, and S. Kornbluth
Phosphorylation of the Cyclin B1 Cytoplasmic Retention Sequence by Mitogen-Activated Protein Kinase and Plx
Mol. Cancer Res., February 1, 2003; 1(4): 280 - 289.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Mood, R. Friesel, and I. O. Daar
SNT1/FRS2 Mediates Germinal Vesicle Breakdown Induced by an Activated FGF Receptor1 in Xenopus Oocytes
J. Biol. Chem., August 30, 2002; 277(36): 33196 - 33204.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement